Client News

Adocia Presents First Half 2019 Financial Results

Atriva Therapeutics Receives EU Award for Biomarker Validation

Motif Bio plc: Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

Heidelberg Pharma reports on first half-year

Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada

Expedeon AG announces Outcome of Annual General Meeting 2019

Ergomed plc: Dr Jim Esinhart, Former CEO of Chiltern International, Proposed Appointment as Non-Executive Director

Biom’up SA: Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year

ADL Bionatur Solutions increases 2019 production for a global nutrition company for additional revenues of over EUR 2.5 million